Physician profile
Chad M Ward
NPI 1477841468
$16,744.60
in general payments reported to CMS, 2019-2025
56 companies · $2,749 in 2025
The $2,749 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,160 · 2020: $1,984 · 2021: $2,208 · 2022: $2,177 · 2023: $2,698 · 2024: $2,769 · 2025: $2,749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,199 · Education: $16.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,198.85 |
| Education | $16.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,121.67 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $2,044.47 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $1,586.66 | 2019-2025 | Evenity, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $1,485.78 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $1,214.74 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,078.75 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Abbvie INC. | $1,071.15 | 2019-2025 | Ubrelvy, Vraylar, Qulipta |
| Pfizer INC. | $962.18 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $678.87 | 2019-2025 | Xarelto, Spravato |
| Otsuka America Pharmaceutical, INC. | $379.85 | 2020-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $343.29 | 2020-2024 | Xifaxan |
| Amarin Pharma, INC. | $308.75 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $302.54 | 2019-2025 | Eliquis, Camzyos |
| Exact Sciences Corporation | $251.51 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $229.85 | 2022 |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $219.23 | 2019-2025 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $175.36 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $169.88 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $167.27 | 2019-2022 | |
| Ibsa Pharma INC. | $146.43 | 2022-2024 | Tirosint, Licart, Licart |
| Merck Sharp & Dohme LLC | $140.99 | 2019-2021 | |
| Dexcom, INC. | $129.44 | 2021-2025 | Dexcom G6 Transmitter |
| Sanofi Pasteur INC. | $104.69 | 2019-2025 | |
| Astellas Pharma US INC | $103.54 | 2022-2025 | Veozah, Myrbetriq |
| Optinose US, INC. | $98.87 | 2021-2023 | |
| Kowa Pharmaceuticals America, INC. | $97.60 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $94.04 | 2024-2025 | Voquezna |
| Bausch Health US, LLC | $92.76 | 2020-2022 | |
| Lundbeck LLC | $86.32 | 2024 | Rexulti |
| Abbott Laboratories | $70.52 | 2021-2024 | Freestyle Libre 3 |
| Axsome Therapeutics, INC. | $68.56 | 2025 | Auvelity |
| Biohaven Pharmaceuticals, INC. | $60.71 | 2020-2021 | |
| Vanda Pharmaceuticals INC. | $46.49 | 2025 | Fanapt |
| Daiichi Sankyo INC. | $45.31 | 2019 | |
| Tactile Systems Technology INC | $44.09 | 2023 | Flexitouch Plus, Entre Plus |
| Nestle Healthcare Nutrition INC. | $41.04 | 2021 | |
| Inspire Medical Systems, INC. | $38.58 | 2024-2025 | Inspire |
| Genzyme Corporation | $38.17 | 2024 | |
| Genentech USA, INC. | $36.07 | 2019-2020 | |
| Ucb, INC. | $36.06 | 2020 | |
| Corcept Therapeutics | $32.52 | 2024 | Korlym |
| Esperion Therapeutics, INC. | $31.32 | 2021-2022 | |
| Radius Health, INC. | $30.72 | 2025 | |
| Idorsia Pharmaceuticals US INC | $29.63 | 2023 | Quviviq |
| Currax Pharmaceuticals LLC | $27.81 | 2025 | Contrave, Onzetra Xsail |
| Sonex Health, INC. | $22.41 | 2025 | Sx-One Microknife |
| Harmony Biosciences LLC | $19.78 | 2025 | |
| Tonix Medicines, INC. | $18.31 | 2025 | Tonmya |
| Xeris Pharmaceuticals, INC. | $18.18 | 2023 | Gvoke Hypopen |
| Almatica Pharma LLC | $16.46 | 2023 | Gralise |
| Cequr Corporation | $16.13 | 2024 | Cequr Simplicity |
| Philips North America LLC | $15.32 | 2023 | |
| Shield Therapeutics INC | $15.24 | 2023 | Accrufer |
| Allergan, INC. | $14.52 | 2020 | |
| Intra-Sana Laboratories | $13.11 | 2023 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Endo Pharmaceuticals INC. | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.